Examples of using Remsima in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Treatment with TNF blockers such as Remsima may result in reactivation of hepatitis B virus in patients who carry this virus,
Remsima is indicated for treatment of moderate to severe plaque psoriasis in adult patients who failed to respond to,
in accordance with EU requirements, Remsima has been shown to have a comparable quality,
Patients with fistulising Crohn's disease with acute suppurative fistulas must not initiate Remsima therapy until a source for possible infection,
Remsima must not be used in patients who have experienced hypersensitivity(allergy) to infliximab in the past, or who are hypersensitive(allergic) to mouse proteins or any of the other ingredients of Remsima.
What you need to know before you use Remsima You must not be given Remsima if you are allergic to infliximab(the active ingredient in Remsima) or any of the other ingredients of this medicine listed in section 6.
blastomycosis are endemic, the benefits and risks of Remsima treatment should be carefully considered before initiation of Remsima therapy.
The safety and efficacy of Remsima in children and adolescents younger than 18 years in the indications juvenile idiopathic arthritis, psoriatic arthritis
Under aseptic conditions, each Remsima vial should be reconstituted with 10 mL of water for injections,
Remsima is indicated for treatment of severely active ulcerative colitis in children and adolescents aged 6 to 17 years,
If you are given too much Remsima.
If you forget or miss your Remsima infusion.
The Committee recommended that Remsima be approved for use in the EU.
A risk for the development for hepatosplenic T-cell lymphoma in patients treated with Remsima cannot be excluded see section 4.8.
The required volume of reconstituted Remsima solution should slowly be added to the 250-mL infusion bottle
The combination of Remsima with other biological therapeutics used to treat the same conditions as Remsima, including anakinra and abatacept, is not recommended see section 4.4.
other healthcare professionals about your Remsima use before your baby receives any vaccine.
The Marketing Authorisation Holder(MAH) shall conduct an educational programme to ensure that all physicians who are expected to prescribe/use Remsima are aware of.
If you received Remsima while you were pregnant,
Patients should be closely monitored and Remsima must not be continued in patients who develop new or worsening symptoms of heart failure see sections 4.3 and 4.8.